Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Byar

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Urology|January 1, 1975
Letters: Rserpine and prostatic cancerD P Byar, C E Blackard
Preventive Medicine|March 1, 1989
Clinical trials in diet and cancerD P Byar, L S Freedman
Urology|November 1, 1973
Does reserpine increase prolactin and exacerbate cancer of prostate? Case control studyH H Newball, D P Byar
Urology|August 1, 1979
Quantitative radiology for staging and prognosis of patients with advanced prostatic carcinoma. Correlations with other pretreatment characteristicsJ A Hovsepian, D P Byar
Journal of Chronic Diseases|May 1, 1973
An analysis of the effects of changes from the assigned treatment in a clinical trial of treatment for prostatic cancerK S Hurst, D P Byar
Urology|April 1, 1981
VACURG randomised trial of radical prostatectomy for stages I and II prostatic cancer. Veterans Administration Cooperative Urological Research GroupD P Byar, D K Corle
Urology|July 1, 1975
Carcinoma of prostate. Correlation between radiologic quantitation of metastases and patient survivalJ A Hovsepian, D P Byar
The Journal of Urology|December 1, 1972
Results of a clinical trial of surgery and radiation in stages II and 3 carcinoma of the bladderC E Blackard, D P Byar
Controlled Clinical Trials|June 1, 1989
Using permutation tests and bootstrap confidence limits to analyze repeated events data from clinical trialsL Freedman, R Sylvester, D P Byar
American Journal of Epidemiology|August 1, 1977
Tests for homogeneity of effect in an epidemiologic investigationN Mantel, C Brown, D P Byar
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Urology|January 1, 1975
Letters: Rserpine and prostatic cancerD P Byar, C E Blackard
Preventive Medicine|March 1, 1989
Clinical trials in diet and cancerD P Byar, L S Freedman
Urology|November 1, 1973
Does reserpine increase prolactin and exacerbate cancer of prostate? Case control studyH H Newball, D P Byar
Urology|August 1, 1979
Quantitative radiology for staging and prognosis of patients with advanced prostatic carcinoma. Correlations with other pretreatment characteristicsJ A Hovsepian, D P Byar
Journal of Chronic Diseases|May 1, 1973
An analysis of the effects of changes from the assigned treatment in a clinical trial of treatment for prostatic cancerK S Hurst, D P Byar
Urology|April 1, 1981
VACURG randomised trial of radical prostatectomy for stages I and II prostatic cancer. Veterans Administration Cooperative Urological Research GroupD P Byar, D K Corle
Urology|July 1, 1975
Carcinoma of prostate. Correlation between radiologic quantitation of metastases and patient survivalJ A Hovsepian, D P Byar
The Journal of Urology|December 1, 1972
Results of a clinical trial of surgery and radiation in stages II and 3 carcinoma of the bladderC E Blackard, D P Byar
Controlled Clinical Trials|June 1, 1989
Using permutation tests and bootstrap confidence limits to analyze repeated events data from clinical trialsL Freedman, R Sylvester, D P Byar
American Journal of Epidemiology|August 1, 1977
Tests for homogeneity of effect in an epidemiologic investigationN Mantel, C Brown, D P Byar
Pageof 9